FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
Noble Financial analyst Gregory Aurand maintained a Buy rating on BioSig Technologies (BSGM β Research Report) today and set a price target of...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...
Filed Pursuant to Rule 424(b)(5) Registration No. 333-251859 PROSPECTUS SUPPLEMENT (To the Prospectus Dated January 12, 2021...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Ma...
Westport, CT, May 11, 2022 (GLOBE NEWSWIRE) -- To date, Company's FDA 510(k) cleared PURE EP(TM) system has...
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURR...
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS β Research Report) and BioSig...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.